These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 11783069
1. [Clinical significance of CD44 expression in ovarian epithelial tumors]. Qu P, Jiao S, Gao Q. Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):46-9. PubMed ID: 11783069 [Abstract] [Full Text] [Related]
2. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Tjhay F, Motohara T, Tayama S, Narantuya D, Fujimoto K, Guo J, Sakaguchi I, Honda R, Tashiro H, Katabuchi H. Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934 [Abstract] [Full Text] [Related]
3. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK, Grelewski P, Popiela A, Noga L, Rabczyñski J. Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 01; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
9. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Cancer Res; 1993 Aug 15; 53(16):3830-8. PubMed ID: 8339295 [Abstract] [Full Text] [Related]
12. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas]. Wang A, Lu L, Wang Y, Sun Y, Zhang Y, Guo C, Gu Y, Liu A. Zhonghua Bing Li Xue Za Zhi; 2014 Jan 15; 43(1):20-4. PubMed ID: 24713244 [Abstract] [Full Text] [Related]
13. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer. Gu L, Shigemasa K, Ohama K. Int J Oncol; 2004 Mar 15; 24(3):671-8. PubMed ID: 14767552 [Abstract] [Full Text] [Related]
16. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Wang P, Wu X, Chen W, Liu J, Wang X. Gynecol Oncol; 2007 Mar 15; 104(3):714-20. PubMed ID: 17204312 [Abstract] [Full Text] [Related]
18. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ. Int J Gynecol Pathol; 2011 May 15; 30(3):205-17. PubMed ID: 21464733 [Abstract] [Full Text] [Related]
19. Expression of CD44 adhesion molecules on human placentae. Choi CH, Roh CR, Kim TJ, Choi YL, Lee JW, Kim BG, Lee JH, Bae DS. Eur J Obstet Gynecol Reprod Biol; 2006 May 15; 128(1-2):243-7. PubMed ID: 16504370 [Abstract] [Full Text] [Related]
20. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. Cannistra SA, DeFranzo B, Niloff J, Ottensmeir C. Clin Cancer Res; 1995 Mar 15; 1(3):333-42. PubMed ID: 9815989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]